He was also an Award Winner and National Finalist for the EY Entrepreneur of the Year Award. Gilead, died Wednesday, September 15, 2021 at his residence. Sign up for the Peninsula Foodist newsletter. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. John R. Martin John R. Martin, age 84, of Winterhaven, CA, passed away Dec. 22, 2022 in Yuma, AZ. On behalf of all of us at Gilead, I extend our deepest condolences to Johns family.. For more information on Gilead Sciences, please visit the companys website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000. Gilead Sciences Statement on Recent Events in Washington, D.C. Gilead Announces New Arm of HIV Womens Prevention Study to Evaluate the Investigational Long-Acting HIV-1 Capsid Inhibitor Lenacapavir in Addition to Descovy for PrEP, Gilead Sciences Statement on The World Health Organizations Updated Veklury (Remdesivir) COVID-19 Treatment Guidelines, https://www.businesswire.com/news/home/20210330006163/en/. And dont come back until the doctor agrees to join us as a medical science liaison, he added. During his time with Gilead, Martin also expanded access to HIV medication in developing countries. Martin, a trained chemist, joined Gilead in 1990, and moved from its research director to chief executive in six years, according to the Times.He served as CEO from 1996 to 2016, and was executive chairman from 2016 until his 2018 retirement. He later received a doctorate in organic chemistry from the University of Chicago. Leave your condolences to the family on this memorial page or send flowers to show you care. Rounding out the plan, Gilead formed a collaboration with BMS for the third drug component, the NNRTI efavirenz, and later for another BMS drug, the protease inhibitor atazanavir.